Literature DB >> 21946094

Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period.

Glenn S Murphy1, Joseph W Szokol, Michael J Avram, Steven B Greenberg, Jesse H Marymont, Jeffery S Vender, Jayla Gray, Elizabeth Landry, Dhanesh K Gupta.   

Abstract

BACKGROUND: The subjective experience of residual neuromuscular blockade after emergence from anesthesia has not been examined systematically during postanesthesia care unit (PACU) stays. The authors hypothesized that acceleromyography monitoring would diminish unpleasant symptoms of residual paresis during recovery from anesthesia by reducing the percentage of patients with train-of-four ratios less than 0.9.
METHODS: One hundred fifty-five patients were randomized to receive intraoperative acceleromyography monitoring (acceleromyography group) or conventional qualitative train-of-four monitoring (control group). Neuromuscular management was standardized, and extubation was performed when defined criteria were achieved. Immediately upon a patient's arrival to the PACU, the patient's train-of-four ratios were measured using acceleromyography, and a standardized examination was used to assess 16 symptoms and 11 signs of residual paresis. This examination was repeated 20, 40, and 60 min after PACU admission.
RESULTS: The incidence of residual blockade (train-of-four ratios less than 0.9) was reduced in the acceleromyography group (14.5% vs. 50.0% control group, with the 99% confidence interval for this 35.5% difference being 16.4-52.6%, P < 0.0001). Generalized linear models revealed the acceleromyography group had less overall weakness (graded on a 0-10 scale) and fewer symptoms of muscle weakness across all time points (P < 0.0001 for both analyses), but the number of signs of muscle weakness was small from the time of arrival in the PACU and did not differ between the groups at any time.
CONCLUSION: Acceleromyography monitoring reduces the incidence of residual blockade and associated unpleasant symptoms of muscle weakness in the PACU and improves the overall quality of recovery.

Entities:  

Mesh:

Year:  2011        PMID: 21946094     DOI: 10.1097/ALN.0b013e3182342840

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  28 in total

Review 1.  Anesthesia and fast-track in video-assisted thoracic surgery (VATS): from evidence to practice.

Authors:  Marzia Umari; Stefano Falini; Matteo Segat; Michele Zuliani; Marco Crisman; Lucia Comuzzi; Francesco Pagos; Stefano Lovadina; Umberto Lucangelo
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Comparison between the effects of deep and moderate neuromuscular blockade during transurethral resection of bladder tumor on endoscopic surgical condition and recovery profile: a prospective, randomized, and controlled trial.

Authors:  C H Koo; S H Chung; B G Kim; B H Min; S C Lee; A Y Oh; Y T Jeon; J H Ryu
Journal:  World J Urol       Date:  2018-07-02       Impact factor: 4.226

3.  Randomized Clinical Trial of Moderate Versus Deep Neuromuscular Block for Low-Pressure Pneumoperitoneum During Laparoscopic Cholecystectomy.

Authors:  Bon-Wook Koo; Ah-Young Oh; Kwang-Suk Seo; Ji-Won Han; Ho-Seong Han; Yoo-Seok Yoon
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

Review 4.  Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.

Authors:  Ana-Marija Hristovska; Patricia Duch; Mikkel Allingstrup; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2017-08-14

Review 5.  Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations.

Authors:  A Thorell; A D MacCormick; S Awad; N Reynolds; D Roulin; N Demartines; M Vignaud; A Alvarez; P M Singh; D N Lobo
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

6.  Flucloxacillin and diclofenac do not cause recurrence of neuromuscular blockade after reversal with sugammadex.

Authors:  Pieter-Jan de Kam; Michiel W van den Heuvel; Peter Grobara; Alex Zwiers; Jean-Luc Jadoul; Erik de Clerck; Steven Ramael; Pierre A M Peeters
Journal:  Clin Drug Investig       Date:  2012-03-01       Impact factor: 2.859

7.  Respiratory events with sugammadex vs. neostigmine following laparoscopic sleeve gastrectomy: a prospective pilot study assessing neuromuscular reversal strategies.

Authors:  Shmuel Evron; Yuri Abelansky; Tiberiu Ezri; Alexander Izakson
Journal:  Rom J Anaesth Intensive Care       Date:  2017-10

8.  Residual Paralysis: Does it Influence Outcome After Ambulatory Surgery?

Authors:  Hassan Farhan; Ingrid Moreno-Duarte; Duncan McLean; Matthias Eikermann
Journal:  Curr Anesthesiol Rep       Date:  2014-12

9.  International survey of neuromuscular monitoring in two European countries: a questionnaire study among Hungarian and Romanian anaesthesiologists.

Authors:  Adrienn Pongrácz; Réka Nemes; Caius Breazu; László Asztalos; Ileana Mitre; Edömér Tassonyi; Béla Fülesdi; Calin Mitre
Journal:  Rom J Anaesth Intensive Care       Date:  2019-04

10.  Residual Curarization and Postoperative Respiratory Complications Following Laparoscopic Sleeve Gastrectomy. The Effect of Reversal Agents: Sugammadex vs. Neostigmine.

Authors:  Tiberiu Ezri; Shmuel Evron; Irina Petrov; Pinhas Schachter; Yitzhak Berlovitz; Mordechai Shimonov
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.